Expand FTH Menu
FTH MENU

Faeth Therapeutics (FTH) closed at $22.05 on November 6, 2026, up 10.7% from the previous close, on volume of 494,186 shares (30-day average 333,798).

Key numbers
  • Last close: $22.05 (November 6, 2026)
  • 52-week range: $13.43 to $42.14
  • Market value: $568.4 million

Data as of November 6, 2026.

FTH Stock Summary and Trading Ideas (Faeth Therapeutics | NASDAQ:FTH)

Faeth Therapeutics (FTH) Frequently Asked Questions

What does Faeth Therapeutics do?

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

What symbol and exchange does Faeth Therapeutics shares trade?

Faeth Therapeutics trades on the NASDAQ stock market under the symbol FTH.

What is Faeth Therapeutics stock price doing today?

As of November 6, 2026, FTH stock price climbed to $22.05 with 494,186 million shares trading.

What is Faeth Therapeutics's Beta?

FTH has a beta of 1.49, meaning it tends to be more sensitive to market movements. FTH has a correlation of 0.01 to the broad based SPY ETF.

How much is Faeth Therapeutics worth?

FTH has a market cap of $568.42 million. This is considered a Small Cap stock.

What are the top ETFs holding Faeth Therapeutics?

The top ETF exchange traded funds that FTH belongs to (by Net Assets): VTI, VXF, XBI, SCHA, IWC.

What are the support and resistance levels for Faeth Therapeutics (FTH)?

FTH support price is $18.34 and resistance is $21.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FTH shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes